hat
Edaravone (non mak, radikut) se yon ajan ak nootwopik ak neuroprotective yo itilize nan bi pou yo ede rekiperasyon newolojik apre ijèsi sèvo egi ak pwochen infarction serebral. [1] Li aji kòm yon antioxydant ki pisan ak fòtman scavenges radikal gratis, pwoteje kont estrès oksidatif ak apoptoz neronal. [2] [3] [4] Li te commercialisés sèlman nan Japon pa Mitsubishi Pharma depi lane 2001. [1] Li se tou commercialisés nan peyi Zend pa Edinburgh famasetik pa mak Non Arone la.
eng
Edaravone (brand name ラジカット, Radicut) is a nootropic and neuroprotective agent used for the purpose of aiding neurological recovery following acute brain ischemia and subsequent cerebral infarction.[1] It acts as a potent antioxidant and strongly scavenges free radicals, protecting against oxidative stress and neuronal apoptosis.[2][3][4] It has been marketed solely in Japan by Mitsubishi Pharma since 2001.[1] It is also marketed in India by Edinburgh Pharmaceuticals by the brand name Arone.